EE363 Cost-Effectiveness Analysis of Adding Tumor Treating Fields Therapy to Temozolomide Versus Temozolomide Only in Patients with Glioblastoma in France
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.629
https://www.valueinhealthjournal.com/article/S1098-3015(23)03759-2/fulltext
Title :
EE363 Cost-Effectiveness Analysis of Adding Tumor Treating Fields Therapy to Temozolomide Versus Temozolomide Only in Patients with Glioblastoma in France
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03759-2&doi=10.1016/j.jval.2023.09.629
First page :
Section Title :
Open access? :
No
Section Order :
10123